Non-Myeloablative Allogeneic Transplantation [electronic resource] /

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

Saved in:
Bibliographic Details
Main Authors: Bashey, Asad. editor., Ball, Edward D. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Boston, MA : Springer US : Imprint: Springer, 2002
Subjects:Medicine., Oncology., Surgical transplantation., Medicine & Public Health., Transplant Surgery.,
Online Access:http://dx.doi.org/10.1007/978-1-4615-0919-6
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:206070
record_format koha
spelling KOHA-OAI-TEST:2060702018-07-30T23:35:25ZNon-Myeloablative Allogeneic Transplantation [electronic resource] / Bashey, Asad. editor. Ball, Edward D. editor. SpringerLink (Online service) textBoston, MA : Springer US : Imprint: Springer,2002.engNon-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.1 Development of allogeneic hematopoietic stem cell transplantation (HSCT) -- 2 Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in nonmyeloablative hematopoietic cell transplantation -- 3 Mobilization of allogeneic peripheral blood progenitor cells -- 4 Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologicmalignancies in experimental and clinical studies -- 5 Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer -- 6 Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice -- 7 Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy -- 8 Outpatient allografting in hematologic malignancies and nonmalignant disorders — applying lessons learned in the canine model to humans -- 9 Non-myeloablative transplants for congenital diseases.Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.Medicine.Oncology.Surgical transplantation.Medicine & Public Health.Oncology.Transplant Surgery.Springer eBookshttp://dx.doi.org/10.1007/978-1-4615-0919-6URN:ISBN:9781461509196
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Oncology.
Surgical transplantation.
Medicine & Public Health.
Oncology.
Transplant Surgery.
Medicine.
Oncology.
Surgical transplantation.
Medicine & Public Health.
Oncology.
Transplant Surgery.
spellingShingle Medicine.
Oncology.
Surgical transplantation.
Medicine & Public Health.
Oncology.
Transplant Surgery.
Medicine.
Oncology.
Surgical transplantation.
Medicine & Public Health.
Oncology.
Transplant Surgery.
Bashey, Asad. editor.
Ball, Edward D. editor.
SpringerLink (Online service)
Non-Myeloablative Allogeneic Transplantation [electronic resource] /
description Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.
format Texto
topic_facet Medicine.
Oncology.
Surgical transplantation.
Medicine & Public Health.
Oncology.
Transplant Surgery.
author Bashey, Asad. editor.
Ball, Edward D. editor.
SpringerLink (Online service)
author_facet Bashey, Asad. editor.
Ball, Edward D. editor.
SpringerLink (Online service)
author_sort Bashey, Asad. editor.
title Non-Myeloablative Allogeneic Transplantation [electronic resource] /
title_short Non-Myeloablative Allogeneic Transplantation [electronic resource] /
title_full Non-Myeloablative Allogeneic Transplantation [electronic resource] /
title_fullStr Non-Myeloablative Allogeneic Transplantation [electronic resource] /
title_full_unstemmed Non-Myeloablative Allogeneic Transplantation [electronic resource] /
title_sort non-myeloablative allogeneic transplantation [electronic resource] /
publisher Boston, MA : Springer US : Imprint: Springer,
publishDate 2002
url http://dx.doi.org/10.1007/978-1-4615-0919-6
work_keys_str_mv AT basheyasadeditor nonmyeloablativeallogeneictransplantationelectronicresource
AT balledwarddeditor nonmyeloablativeallogeneictransplantationelectronicresource
AT springerlinkonlineservice nonmyeloablativeallogeneictransplantationelectronicresource
_version_ 1756268198396690432